AnnouncementsWyeth: Updates on outcome of board meeting
AnnouncementsWyeth: Outcome of board meeting
AnnouncementsWyeth to consider final dividend on April 28, 2014
100% of moneycontrol users recommend buying Wyeth.
What's your call on Wyeth today?
Read 1 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2735.85||0.61||2939.80||2140.35||46,601.11|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
AIA Engineering Recommended on May 7th 2014
Recommended price 642.00 | Peak from reco 858.00 33.64%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Wyeth is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 2,136.59 crore.The company has reported a standalone sales of Rs 178.22 crore and a Net Profit of Rs 29.90 crore for the quarter ended Mar 2014.
The company management includes Pradip Shah - Chairman, Darius Udwadia - Director, Sunil Lalbhai - Director, Sekhar Natarajan - Director, Vivek Dhariwal - Director, S Sridhar - Director.
It is listed on the BSE with a BSE Code of 500095 and the NSE with an NSE Code of WYETH.
Its Registered office is at Level 6, Platina, 'Plot No C - 59, 'G' Block,',Bandra - Kurla Complex, Mumbai,Maharashtra - 400098.
Their Registrars are Karvy Computershare Private Ltd.